Raise closed, search for fresh raises on Seedstage

Cheyenne, WY

Commercializing a patented at-home blood test system to modernize pet health diagnostics.

• Exclusive technology: Holds the exclusive license for a patented dry blood collection card in the pet healthcare space.
• First-mover advantage: Only in-home pet testing solution offering blood sample analysis.
• Convenient & stress-free: Designed to reduce vet visits, anxiety, and cost for pet owners.
• Multiple revenue streams: Includes kit sales, app subscriptions, and potential service expansion.
• High-growth market: Positioned in the fast-expanding pet health industry with significant unmet demand.

CheckMyPet XP is raising capital to bring in-home blood sample collection for pets to market, pioneering a first-of-its-kind diagnostic approach in the pet healthcare industry. By utilizing a patented dry blood collection card, CMP eliminates the need for traditional vet visits and cold storage, offering a stress-free, cost-effective, and convenient alternative for pet owners. The kits allow for early detection of potential health issues from home, reducing the financial and emotional burdens commonly associated with veterinary diagnostics. This offering supports the commercialization of a solution that brings professional-grade blood testing capabilities directly into the hands of pet owners, with reliable lab results available within days.

Funds raised will be used to validate test panels, purchase inventory, and support initial operations ahead of larger planned capital raises. CMP holds the exclusive license for the patented technology in the pet market and aims to lead a new category in veterinary care. Its business model includes direct-to-consumer sales, partnerships with pet care professionals, and recurring revenue streams such as an app subscription and future expansion into additional in-home health products. With a growing pet-owning population and increasing demand for health and wellness solutions, CMP is positioned to reshape how pet owners manage their animals’ health. The offering provides investors an opportunity to participate in a high-growth, underserved segment of the pet diagnostics industry.

Company Info

CheckMyPet XP provides patented in-home blood testing kits for pets, offering a first-of-its-kind solution for early health detection and convenience.

CheckMyPet XP (CMP) offers in-home blood sample collection kits for pets, enabling early detection of health issues through a convenient, stress-free process. As the first company to offer blood-based at-home diagnostics for pets, CMP’s patented dry blood collection technology allows pet owners to test for a wide range of health conditions without visiting a vet. The collection cards are easy to use, don’t require refrigeration, and maintain sample stability in high temperatures, making the process both reliable and pet-friendly. CMP provides panels that empower owners to act proactively on their pets’ health, improving outcomes while reducing costs.

The business model includes direct-to-consumer sales, wholesale partnerships, a mobile vet tech network, app subscriptions, and merchandising. CMP holds an exclusive license to its blood collection technology and partners with certified labs for fast results. With a rapidly growing pet health market, CMP addresses unmet demand for accessible, accurate diagnostics. Their technology disrupts traditional veterinary models by removing key barriers such as cost, time, and pet stress. Positioned as the first mover in this emerging category, CMP is aiming to scale through a planned capital raise while maintaining a leadership position in at-home pet diagnostics.